Chai Discovery vs Isomorphic Labs IsoDDE
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Chai Discovery
The AI platform designing novel antibodies and biologics from scratch...
Visit
|
Isomorphic Labs IsoDDE
DeepMind's AI Drug Design Engine that doubles AlphaFold 3 accuracy in...
Visit
|
|
|---|---|---|
| RECATOOLS Score | 8.5 / 10 | 8.2 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Freemium | Enterprise |
| Free tier | Chai-1 fully free — web interface + Apache 2.0 code/weights for academic and commercial use | None — no free or academic tier publicly available |
| Paid from | Chai-2 enterprise access: gated, custom pricing (Eli Lilly pays mid-eight figures annually) | Enterprise partnership only; deals structured around R&D milestones (not per-seat or API) |
| Has API | ✓ | ✗ |
| Open source | ✓ | ✗ |
| Free to use | ✓ | ✗ |
| Users | Chai-1 widely cited as a leading AlphaFold-3 alternative | Not publicly disclosed; access limited to pharma partnership cohort |
| Founded | 2024 | 2021 |
| Maker | Independent (private) | Alphabet Inc. (via Google DeepMind spinoff) |
| Verdict | Chai Discovery is one of the most technically credible AI drug discovery platforms of 2025–2026. Chai-1's open-source Apache 2.0 release gives academic and commercial researchers immediate, zero-cost access to state-of-t... |
Isomorphic Labs IsoDDE represents a genuine scientific leap in AI-driven drug design — its 50% accuracy on the hardest protein-ligand prediction benchmark, outperformance of physics-based gold standards in binding affini... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.